DRUG-INDUCED LIVER INJURIES


如何引用文章

全文:

详细

The article discusses the problem of drug-induced liver injuries due to toxic effects of drugs, dietary supplements and alternative medicine resources. Options of drug-induced liver injuries, principles of diagnosis, treatment and prevention of hepatotoxicity are represented. Physicians awareness has a great importance for the prevention of hepatotoxicity, because the timely cessation of drug allows to avoid more severe liver injury. Investigations of the prophylactic effect of some drugs that have a beneficial effect on liver function, particularly S-adenosyl-L-methionine (ademethionine) and ursodeoxycholic acid, are most promising.

参考

  1. Ostapowicz G, Fontana R, Schiodt F, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
  2. Russo M, Galanko J, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10(8):1018-23.
  3. Teschke R. [Drug-induced liver diseases]. Z Gastroenterol 2002;40(5):305-26.
  4. Лопаткина Т.Н., Бурневич Э.З. Лекарственные поражения печени. В кн. Н.А. Мухин (ред.). Практическая гепатология. М., 2004. С. 133-6.
  5. Lee W. Drug-induced hepatotoxicity. N Engl J Med, 2003;349:474-85.
  6. Robin M-A, Le Roy M, Descatoire V, et al. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol 1997;26:23-30.
  7. Villeneuve J, Pichette V. Cytochrome P450 and liver diseases. Curr Drug Metab 2004;5(3): 273-82.
  8. Jaeschke H, Gores G, Cederbaum A. et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;66:166-76.
  9. Reed J. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001; 7:314-19.
  10. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin. Liver Dis 2001;21:57-69.
  11. DeLeve L, Shulman H, McDonald G. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27-42.
  12. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195-206.
  13. Gunawan B, Kaplowitz N. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev 2004;36(2):301-12.
  14. Andrade R, Camargo R, Lucena M, et al. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 2004;3(4):329-44.
  15. Dart R, Horowitz R, McDonald F. Lessons from experience with acetaminophen overdose. OTC analgesic use. Special report 1996;75-84.
  16. Prescott L. Paracetamol. A critical bibliographic review. Taylor & Francis Ltd 1996.
  17. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5.
  18. Nolan C, Goldberg S, Buskin S. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014-18.
  19. Sulkowski M. Hepatotoxicity associated with antiretroviral therapy containin HIV-1 protease inhibitors. Semin Liver Dis 2003;23(2):183-94.
  20. King P, Perry M. Hepatotoxicity of chemotherapy. Oncologist 2001;6(2):162-76.
  21. Smet P. Herbal medicines. N.Engl J Med 20024;347(25):2046-56.
  22. Santini D, Vincenzi B, Massacesi C, et al. S-Аденозилметионин (Гептрал) в лечении поражения печени, вызванного химиотерапией. Anticancer Res 2003;23:5173-80.
  23. Lieber C. S-Adenosyl-L-methionine: its role in the treatment of liverdisorders. Am J Clin Nutr 2002;76:1183-7.
  24. Mato J, Corrales F, Lu S, et al. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002;16:15-26.
  25. Nei S, Signorelli S, Sterna D, et al. Роль адеметионина (S-аденозилметионина) в профилактике холестаза, вызванного циклоспорином. Clin. Drug Invest 2002;22(3):191-5.
  26. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002;22(2):145-55.
  27. Takikawa H, et al. Lessons from ticlopidine-induced liver injury. Hepatol Res 2005;33(3):193-94.
  28. Vincenzi B, Santini D, Frezza AM, et al. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen. Expert Opin Drug Saf 2011;10(3):345-49.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2011
##common.cookie##